Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study-Reference-Cited by-同舟云学术

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study

Published:2016-05 Issue:5 Volume:74 Page:841-850
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Papp Kim A.,Krueger James G.,Feldman Steven R.,Langley Richard G.,Thaci Diamant,Torii Hideshi,Tyring Stephen,Wolk Robert,Gardner Annie,Mebus Charles,Tan Huaming,Luo Yingchun,Gupta Pankaj,Mallbris Lotus,Tatulych Svitlana

Publisher

Elsevier BV

Subject

Dermatology

Reference17 articles.

1. Continuous versus intermittent therapy for moderate-to-severe psoriasis;Ramirez-Fort;Clin Exp Rheumatol,2013

2. Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011;Armstrong;JAMA Dermatol,2013

3. Definition of treatment goals for moderate to severe psoriasis: a European consensus;Mrowietz;Arch Dermatol Res,2011

4. Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey;Horn;J Am Acad Dermatol,2007

5. Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey;van de Kerkhof;J Eur Acad Dermatol Venereol,2015

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment strategies for Spondyloarthritis: Implementation of precision medicine – Or “one size fits all” concept?;Autoimmunity Reviews;2024-09

2. Real-World Experience With Janus Kinase Inhibitors in Immune-Mediated Diseases: Clinical Experience of a University Hospital;Cureus;2024-08-25

3. Oral Psoriasis Therapies;Dermatologic Clinics;2024-07

4. Transcriptomics- and Genomics-Guided Drug Repurposing for the Treatment of Vesicular Hand Eczema;Pharmaceutics;2024-03-30

5. Efficacy and safety of tofacitinib for chronic plaque psoriasis and psoriatic arthritis: a systematic review and meta-analysis of randomized controlled trials;Clinical Rheumatology;2024-03-22